X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ABBOTT INDIA LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  
Boost Trading
Profits in Four
Easy Steps
DOWNLOAD NOW!

ABBOTT INDIA LIMITED  (KNOL)


Here is the latest financial fact sheet of Abbott India. For more details, see the Abbott India quarterly results and Abbott India share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
abbott india - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 4,500.4       No. of shares m 21.25
    Mkt Cap Rs m 95,634       % ch % -0.9
    Vol '000 0.3       % ch week % 1.3
    P/E X 32.6       % ch 1-mth % 2.9
    P/CF X 34.9       % ch 12-mth % -7.7
    EPS (TTM) Rs 138.2       52 week H/L Rs 5,220.0/4,351.0
(As on Feb 22, 2017 03:36:00 PM) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Dec-11
12
Dec-12
15
Mar-14
12
Mar-15
12
Mar-16
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs1,6831,8071,7934,1196,015 
Low Rs1,1781,3751,3003,7003,707 
Sales per share (Unadj.) Rs701.3777.71,080.91,077.31,236.9 
Earnings per share (Unadj.) Rs56.768.193.4107.7122.2 
Diluted earnings per shareRs56.768.193.4107.7122.2 
Cash flow per share (Unadj.) Rs63.777.3103.7114.8129.0 
Dividends per share (Unadj.) Rs17.0017.0023.0031.0035.00 
Adj. dividends per shareRs17.0017.0023.0031.0035.00 
Dividend yield (eoy) %1.21.11.50.80.7 
Book value per share (Unadj.) Rs256.0304.4370.8441.2521.2 
Adj. book value per shareRs256.0304.4370.8441.2521.2 
Shares outstanding (eoy) m21.2521.2521.2521.2521.25 
Bonus/Rights/Conversions  A---- 
Price / Sales ratio x2.02.01.43.63.9 
Avg P/E ratio x25.323.416.636.339.8 
P/CF ratio (eoy) x22.520.614.934.137.7 
Price / Book Value ratio x5.65.24.28.99.3 
Dividend payout %30.025.024.628.828.6 
Avg Mkt Cap Rs m30,39833,80932,85883,079103,296 
No. of employees `0002.42.72.82.93.0 
Total wages/salary Rs m1,6732,0622,9973,0543,370 
Avg. sales/employee Rs Th6,145.26,196.88,304.07,985.18,891.8 
Avg. wages/employee Rs Th689.9773.21,083.71,065.21,140.0 
Avg. net profit/employee Rs Th496.4542.6717.5798.6878.3 
  INCOME DATA
Net Sales Rs m14,90216,52722,96922,89326,284 
Other income Rs m197223482476504 
Total revenues Rs m15,09916,75023,45123,36926,789 
Gross profit Rs m1,7552,0182,6833,1233,665 
Depreciation Rs m150195219149144 
Interest Rs m00158 
Profit before tax Rs m1,8022,0462,9463,4444,017 
Minority Interest Rs m00000 
Prior Period Items Rs m-430000 
Extraordinary Inc (Exp) Rs m0104000 
Tax Rs m5557039611,1541,421 
Profit after tax Rs m1,2041,4471,9852,2902,596 
Gross profit margin %11.812.211.713.613.9 
Effective tax rate %30.834.432.633.535.4 
Net profit margin %8.18.88.610.09.9 
  BALANCE SHEET DATA
Current assets Rs m6,8637,7399,96512,26114,446 
Current liabilities Rs m2,3852,29630,6123,9694,725 
Net working cap to sales %30.032.9-89.936.237.0 
Current ratio x2.93.40.33.13.1 
Inventory Days Days6258576151 
Debtors Days Days3231172120 
Net fixed assets Rs m8001,0929951,0001,113 
Share capital Rs m212213213213213 
"Free" reserves Rs m5,1736,2007,6109,10710,808 
Net worth Rs m5,4416,4697,8799,37511,076 
Long term debt Rs m00000 
Total assets Rs m7,9139,07111,39213,73616,241 
Interest coverage xNM10,231.03,682.9689.7497.0 
Debt to equity ratio x00000 
Sales to assets ratio x1.91.82.01.71.6 
Return on assets %15.216.017.416.716.0 
Return on equity %22.122.425.224.423.4 
Return on capital %32.333.237.436.836.3 
Exports to sales %0.40.70.60.50.6 
Imports to sales %7.910.715.99.912.6 
Exports (fob) Rs m59120141122162 
Imports (cif) Rs m1,1761,7643,6592,2643,322 
Fx inflow Rs m113179240215268 
Fx outflow Rs m1,5172,1174,0412,7373,927 
Net fx Rs m-1,404-1,937-3,801-2,523-3,659 
  CASH FLOW
From Operations Rs m 241 1,014 1,545 2,148 2,514 
From Investments Rs m 51 -585 -1,431 -1,867 -800 
From Financial Activity Rs m -420 -420 -424 -576 -803 
Net Cashflow Rs m -129 8 -309 -295 912 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for abbott india limited

 Share Holding
Indian Promoters : 0.0%
Foreign collaborators : 75.0%
Indian inst/Mut Fund : 7.9%
FIIs : 0.1%
ADR/GDR : 0.0%
Free float : 17.1%
Shareholders : 18,270
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: 3-4, Corporate Park, Sion Trombay Road, Mumbai - 400 071
    E-MAIL: investor.relations@abbott.co.in     WEB: www.abbott.co.in
    TELEPHONE: (022) 6797 8888     FAX: (022) 6797 8727
    SECTOR: PHARMACEUTICALS     GROUP: M N C
    TR AGENT: Sharepro Serv., 13 AB, Samhita Warehousing, 2nd Flr, Andheri (E), Mumbai-72
    AUDITOR: Deloitte Haskins & Sells
CHM: Munir Shaikh COMP SEC: Krupa Anandpara YEAR OF INC: 1944 BSE CODE: 500488 FV (Rs): 10 DIV YIELD (%): 0.8

More pharmaceuticals Company Fact Sheets:   LUPIN LTDINDOCO REMEDIESCIPLAPANACEA BIOTECHGSK PHARMA


Today's Market

Sensex Trades on a Positive Note; IT Stocks Drag(01:30 pm)

After opening the day marginally higher, share markets in India have continued to remain strong and are trading above the dotted line. Sectoral indices are trading on a mixed note with stocks in the oil & gas sector.

Views on news

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

Glenmark: High Costs hit the Bottom line (Quarterly Results Update - Detailed)

Nov 8, 2016

Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

More Views on News

Most Popular

My Six Rules for Stock Picking(Outside View)

Feb 11, 2017

A wealth-building strategy is more than just about how to pick good stocks.

18.24% Gains in 19 Days... And I Am Still Disappointed(Daily Profit Hunter)

Feb 14, 2017

Apurva closed a trade with gains of 18.24% for his Swing Trader subscribers. But he's not happy about it. Find out why.

India's Ecommerce Ponzi Scheme Has Started to Unravel(Vivek Kaul's Diary)

Feb 15, 2017

The investors are writing down their investments in these firms.

Rahul Shah: 'Let Your "Mirror Neurons" Do the Magic with Stocks...'(The 5 Minute Wrapup)

Feb 10, 2017

If you understand this powerful neurological phenomenon and harness it smartly, you can be successful at anything you choose.

Being Rich Is Not Just About Having Money in the Bank(Outside View)

Feb 17, 2017

What does having wealth really mean. Have you ever defined it for yourself?

More

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ABBOTT INDIA

ABBOTT INDIA - ADCOCK INGRAM COMPARISON

Compare Company With Charts

COMPARE ABBOTT INDIA WITH

MARKET STATS